Why Did Frank Macfarlane Burnet win the Nobel Prize in 1960?
Frank Macfarlane Burnet: The Nobel Prize Winner Who Shaped Modern Immunology
If you asked most people to name a famous Australian scientist, you'd probably hear Howard Florey, the man behind penicillin's development into a usable drug. Maybe Peter Doherty, or more recently, Elizabeth Blackburn. Far fewer people would say Frank Macfarlane Burnet — and that's a genuine oversight, because his ideas quietly underpin almost everything modern medicine understands about the immune system.
Burnet never discovered a single blockbuster drug. He did something arguably more foundational: he figured out how the immune system tells the difference between "you" and "not you." Understanding that distinction is the reason organ transplants can work at all, and part of the theoretical groundwork beneath modern cancer immunotherapy.
Take the poll above — chances are, Burnet is the name you're least sure about. By the end of this post, he might be the one you know best.
From Virologist to Immunologist
Burnet was born in 1899 in Traralgon, a small town in regional Victoria, and completed his medical training at the University of Melbourne. He wasn't a naturally gifted clinician — colleagues noted he lacked the interpersonal warmth the job demanded — so when the Walter and Eliza Hall Institute (WEHI) offered him a lab research post instead of a hospital position in 1923, it turned out to be exactly the right fit.
After further training in London, Burnet spent the 1930s and '40s building a formidable reputation as a virologist. In 1944, he became director of WEHI, a role he'd hold for two decades. Then he made a decision that puzzled his own colleagues: he began winding down the institute's virus research and steering it almost entirely toward immunology instead. Gustav Nossal, who later succeeded him as director, arrived at WEHI in 1957 expecting to work under "the world's greatest virologist," only to find him dismantling the very program that had made his name.
That pivot led Burnet to the question that would define the rest of his career: how does the immune system generate the near-limitless variety of antibodies it needs, while still knowing not to attack the body's own cells?
Clonal Selection: A Theory That Rewrote Immunology
At the time, the leading idea in immunology was that antibodies took their shape directly from whatever foreign invader they encountered — as if the body molded each antibody around the germ like a key being cut to match a lock. Burnet proposed something radically different: that the body already contains a vast, pre-existing library of immune cells, each one randomly generated to recognize one specific target before ever meeting it. When one of those cells happens to encounter a matching invader, it doesn't reshape itself — it multiplies, cloning itself into an army built to fight that one threat.
This idea, published in 1957 and expanded into a book two years later, became known as the clonal selection theory. It explained not just how the immune system fights specific invaders, but — crucially — how it avoids attacking the body's own tissue: cells that would react against "self" are eliminated or suppressed early on, rather than ever being allowed to multiply.
The Nobel Prize: Acquired Immunological Tolerance
Burnet's theoretical work led directly to the discovery that won him the 1960 Nobel Prize in Physiology or Medicine, shared with British biologist Peter Medawar, "for discovery of acquired immunological tolerance."
The core idea: the immune system isn't born already knowing what counts as "self." It learns that distinction during a critical window early in development. Medawar's experiments confirmed what Burnet had theorized — that if foreign cells are introduced during that early window, the body can be trained to accept them later in life, rather than attacking them as invaders.
This is the theoretical foundation beneath every successful organ transplant performed since. Before Burnet and Medawar's work, rejection was a poorly understood mystery. Afterward, it was a problem that could, in principle, be solved.
A Legacy Bigger Than One Prize
Burnet spent 59 years at WEHI, reshaping it from a modest pathology lab into a world leader in immunology — and the institute he built would go on to produce two more Lasker laureates in the decades after him, Donald Metcalf and Jacques Miller, both working on ideas that trace back to the immunological questions Burnet first insisted the institute take seriously.
He isn't a household name the way Florey or Doherty might be — even in Melbourne, where the Burnet Institute bears his name, most people walking past it couldn't tell you why. But almost every modern breakthrough involving the immune system — from transplant medicine to cancer immunotherapy to autoimmune disease treatment — rests on a theoretical shift Burnet forced through decades before any of it was possible.